{"nct_id":"NCT06790966","title":"Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2025-05-30","start_date_type":"ACTUAL","primary_completion_date":"2029-02","primary_completion_date_type":"ESTIMATED","completion_date":"2029-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PDSB"]}